• MK0787 vs Cefoperazone: 1982 β-Lactam Evidence

  2026-10-08

  Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with several newer β-lactams across resistant clinical isolates, highlighting especially strong activity against Pseudomonas aeruginosa and Acinetobacter spp. The study also showed that MK0787 was bactericidal against the tested gram-negative isolates and that its activity was not obviously reduced by β-lactamase production, while cefoperazone served as an important comparator rather than the principal innovation.

• Keap1–Nrf2 Inhibition and Neuronal Ferroptosis in AD

  2026-10-08

  The reference study identifies compound 4–95 as a selective Keap1–Nrf2 protein–protein interaction inhibitor that suppresses ferroptosis-related neuronal injury in cellular and mouse models of Alzheimer’s disease. Its main contribution is linking Nrf2 activation, GPX4/SLC7A11 preservation, reduced amyloid and Tau pathology, and improved cognitive performance within one preclinical framework.

• How HIV-1 Remodels Nuclear Pores in Resting T Cells

  2026-10-07

  Mesner and colleagues show that HIV-1 cell–cell spread can make resting CD4+ T cells permissive by activating CD4–LCK–CDK1 signalling and remodeling nuclear pore complexes. The study shifts attention from viral dose alone to contact-dependent control of capsid nuclear import, while also defining important limits on how in vitro findings should be applied to infection in vivo.

• LDN-193189 in BMP and Corneal Epithelial Research

  2026-10-07

  LDN-193189 is an ALK inhibitor used as a research tool to examine BMP signaling, but the strongest supplied evidence concerns its inclusion in a six-component culture system rather than isolated drug activity. This overview compares the supplier’s mechanistic claims with findings from a peer-reviewed mouse corneal epithelial study and defines the limits of translation.

• 3-Deazaadenosine: Methylation Research Context

  2026-10-06

  3-Deazaadenosine is a supplier-described S-adenosylhomocysteine hydrolase inhibitor used to study methylation-dependent biology and preclinical antiviral research. This overview separates that biochemical rationale from findings in a 2024 ulcerative colitis study of METTL14, highlighting what the evidence supports, where comparisons are only conceptual, and why the reported pathway cannot be treated as proof of 3-Deazaadenosine activity.

• Q-VD(OMe)-OPh in Mixed Cell Death Research

  2026-10-06

  Q-VD(OMe)-OPh offers a useful way to interpret caspase dependence when apoptosis overlaps with ferroptosis and autophagy. This evidence-focused guide connects Q-VD-OPh to cetuximab-resistant colorectal cancer research while defining its limits in apoptosis assays, AML differentiation, and neuroprotection.

• Q-VD(OMe)-OPh: Evidence and Limits

  2026-10-05

  A source-grounded overview of Q-VD(OMe)-OPh that explains its caspase-inhibition principle, evaluates the strength of available evidence, interprets its relevance to a colorectal cancer study, and defines important limits for apoptosis research, acute myeloid leukemia differentiation, and neuroprotection in ischemic stroke.

• Potato Virus X as an RNA Delivery Platform

  2026-10-05

  A 2025 Scientific Reports study presents potato virus X coat protein as a modular scaffold for assembling filamentous and halo-shaped nucleoprotein nanoparticles around mRNA and circRNA. The work demonstrates programmable assembly, mixed coat-protein architectures, length control, and reporter-protein expression in eukaryotic cells, while remaining an early proof of concept rather than a validated therapeutic platform.

• SCH772984 HCl: ERK Evidence and Limits

  2026-10-04

  This source-grounded overview explains what SCH772984 HCl can reveal about ERK1/2 and MAPK signaling, how the supplied mouse study connects ERK inhibition with KLF4 and Agrp transcription, and why those findings should not be generalized to human metabolism or cancer treatment.

• Carbapenemase Dynamics in CREC Across Guangdong

  2026-10-03

  A multicenter study of 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals combined resistance-gene detection, gene-location analysis, transfer assessment, mobile-element profiling, and strain typing. The findings identify plasmid-associated blaNDM-1 as a dominant concern while showing why gene mobility, clonal relatedness, and hospital-level surveillance should be interpreted together.

• β-Elemene Inhibits Adipogenesis via AMPK

  2026-10-01

  The reference study identifies β-elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 cells and links this effect to recovery of AMPK-pathway activity. Its integrated lipid, glucose-handling, viability, and gene-expression workflow provides a practical framework for investigating β-elemene and the related name Levo-β-elemene in cellular obesity and insulin-resistance models.

• Acid-Responsive Polymers Improve RNA Transfection

  2026-10-01

  Cheung, Fuchs, and Shoichet developed acid-responsive polymer additives that improve RNA dissociation from lipid nanoparticles after endosomal disruption, rather than primarily increasing uptake or endosomal escape. Hybrid polymer–lipid nanoparticles enhanced siRNA potency and mRNA transfection across cell-based models, providing a practical strategy for improving payload utilization while avoiding more aggressive membrane-disruptive designs.

• Irinotecan: From DNA Damage to Translation

  2026-09-30

  A mechanism-led guide to using Irinotecan and CPT-11 in colorectal cancer research, connecting prodrug activation, assay design, xenograft validation, and the translational implications of chemotherapy-induced nausea and vomiting.

• Rucaparib and the Next Frontier of DDR Signaling

  2026-09-30

  Rucaparib (AG-014699, PF-01367338) offers a mechanistically rich platform for studying PARP1 inhibition, persistent DNA damage, radiosensitization, and context-dependent apoptosis. This thought-leadership perspective connects established DNA repair biology with emerging evidence that RNA Pol II loss can actively signal cell death, while distinguishing validated mechanisms from testable translational hypotheses.

• RSL3–PARP1 Crosstalk in Ferroptosis and Apoptosis

  2026-09-29

  The 2025 study identifies PARP1 as a mechanistic bridge between RSL3-induced ferroptosis and apoptosis, revealing both caspase-dependent PARP1 cleavage and depletion of full-length PARP1 through altered m6A-mediated translation. Its findings connect redox stress, epigenetic RNA regulation, and PARPi-resistant tumor growth, while suggesting that ferroptosis studies benefit from orthogonal measurements of caspase signaling and PARP1 status.

8855 records 2/591 page Previous Next 12345 下5页 Last page